Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Puvatherapy and systemic lupus erythematosus].

C A Bianchi, R Milicich, O Stringa

    Medicina Cutanea Ibero-Latino-Americana
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis.

    Clinical and experimental dermatology·1994
    Same author

    Ultra-short topical treatment of pityriasis versicolor with 2.5% bifonazole cream.

    Clinical and experimental dermatology·1993
    Same author

    [Chronic benign familial pemphigus. Clinical, histological and immunological study of 7 cases].

    Medicina cutanea ibero-latino-americana·1985
    Same author

    [Cutaneous manifestations of the malabsorption syndrome].

    Medicina cutanea ibero-latino-americana·1984
    Same author

    [Ampicillin and infectious mononucleosis. Skin manifestations].

    Medicina cutanea ibero-latino-americana·1983
    Same author

    Hereditary complement (C2) deficiency with discoid lupus erythematosus and idiopathic atrophoderma.

    International journal of dermatology·1979
    Same journal

    [Acquired bullous epidermolysis and multiple myeloma].

    Medicina cutanea ibero-latino-americana·1990
    Same journal

    [Eosinophilic ulcer of the tongue. Pathogenic role of eosinophils].

    Medicina cutanea ibero-latino-americana·1990
    Same journal

    [Facial granuloma caused by cactus bristles].

    Medicina cutanea ibero-latino-americana·1990
    Same journal

    [Epithelioid sarcoma. Immunohistochemical study. Therapy with recombinant alfa interferon].

    Medicina cutanea ibero-latino-americana·1990
    Same journal

    [Dyshidrosiform pemphigoid].

    Medicina cutanea ibero-latino-americana·1990
    Same journal

    [Metastatic alopecia].

    Medicina cutanea ibero-latino-americana·1990
    See all related articles

    Psoralen plus ultraviolet A (PUVA) therapy can trigger autoimmune hemolytic anemia and lupus-like symptoms. Careful clinical and serological monitoring is crucial to manage potential iatrogenic risks associated with PUVA treatment.

    Area of Science:

    • Dermatology
    • Immunology
    • Internal Medicine

    Background:

    • Psoralen plus ultraviolet A (PUVA) therapy is a common phototherapy for skin conditions.
    • Photosensitivity reactions can manifest in various ways, including autoimmune phenomena.
    • Previous reports have linked PUVA therapy to lupus erythematosus-like syndromes.

    Observation:

    • A patient developed autoimmune hemolytic anemia, fever, and polyarthralgias post-PUVA therapy.
    • Laboratory findings included accelerated ESR, complement consumption, low C4 and C3 levels, and high ANA titers.

    Findings:

    • The observed symptoms suggest a potential link between PUVA therapy and the induction of autoimmune responses.
    • Long-wave ultraviolet light exposure may act as a precipitating factor for autoimmune phenomena.

    Related Experiment Videos

  • A discrepancy exists regarding whether PUVA-induced alterations are antigenic, requiring further clarification.
  • Implications:

    • This case highlights the iatrogenic risk of PUVA therapy in potentially triggering autoimmune conditions.
    • Close clinical and serological monitoring is essential for patients undergoing PUVA treatment.
    • Further research is needed to elucidate the exact mechanisms and resolve conflicting findings regarding PUVA's role in autoimmunity.